Answer
All patients receiving Ruconest (conestat alfa) must be closely monitored and carefully observed for symptoms of hypersensitivity during and after administration.
Sources for this answer
- Ruconest 2100 U powder for solution for injectionPharming Group N.V. · emc · SmPC §4.4 Special warnings and precautions for use · Version 4Document updated
Sources checked